38 citations
,
September 2017 in “Journal of zoo and wildlife medicine” This study describes the successful management of Andean bear alopecia syndrome in three female bears using oclacitinib, leading to rapid pruritus resolution and fur regrowth without adverse effects.
19 citations
,
April 2019 in “Veterinary dermatology” This study observed that oclacitinib, combined with oral glucocorticoids, achieved rapid and lasting clinical remission in four dogs with refractory juvenile-onset ischaemic dermatopathy, suggesting oclacitinib's potential as a useful immunosuppressive treatment in such cases.
April 2026 in “Veterinary Dermatology” In this case report, a 6-year-old miniature jenny with pemphigus foliaceus was effectively treated with oclacitinib maleate, with and without low-dose prednisolone, over four years without adverse effects.
June 2025 in “Veterinary Sciences” In this case study, a neutered British Shorthair cat with diabetes mellitus showed fast remission of facial skin issues using off-label oclacitinib, with no recurrence for 17 months, but required surgery for eyelid cicatrization.
6 citations
,
January 2019 in “Journal of feline medicine and surgery open reports” This case report describes the first known occurrence of urticaria pigmentosa in a domestic shorthair cat, where oral dexamethasone and cetirizine hydrochloride offered effective management following a comprehensive diagnostic work-up.